Title
Characterization of Death Receptor 5 Targeting Nanoring Cancer Drugs
Abstract
To maximize the effectiveness and minimize the adverse effects of chemotherapeutic agents, it is strategic to create drugs that specifically target cancer cells via ligand-receptor interactions. Several variations of a drug containing a ligand that binds to Death Receptor 5 were created and in vitro properties were characterized.
Description
Faculty Advisor: Dr. Carston R. Wagner
Funding information
This research was supported by the Undergraduate Research Opportunities Program (UROP).
Suggested Citation
Palmatier, Katelyn.
(2012).
Characterization of Death Receptor 5 Targeting Nanoring Cancer Drugs.
Retrieved from the University of Minnesota Digital Conservancy,
https://hdl.handle.net/11299/133312.